# Pharmacokinetics (PK) of Ertapenem Intravenous (IV) Bolus Versus Standard Infusion

> **NCT01148771** · PHASE4 · COMPLETED · sponsor: **Hartford Hospital** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ertapenem
- **DRUG:** ertapenem

## Key facts

- **NCT ID:** NCT01148771
- **Lead sponsor:** Hartford Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2012-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01148771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01148771, "Pharmacokinetics (PK) of Ertapenem Intravenous (IV) Bolus Versus Standard Infusion". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01148771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*